BioRationality: Questioning Experts and Journals Reporting on Biosimilar Bill to Remove Interchangeability
June 23rd 2025
By Sarfaraz K. Niazi, PhD
ArticleThe debate over the Biosimilar Red Tape Elimination Act raises critical concerns about FDA standards, physician trust, and patient safety in biosimilars.